This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Novimaune S.a., Other. Active years: 1992-2002.
Location History:
- 1292 Chambesy, Geneva, CH (1992 - 1999)
- Chambésy, CH (2002)
Company Filing History:
1 out of 1 
2 out of 834,453 Years Active: 1992-2002
Title: Bernard F Mach: Innovator and Inventor in Molecular Biology
Introduction
Bernard F Mach, based in 1292 Chambesy, Geneva, CH, is a notable inventor who has made significant contributions to the field of molecular biology. With a portfolio of three patents, he focuses on methods that advance our understanding of gene expression and molecular interactions, particularly in relation to MHC class II genes.
Latest Patents
Among his notable patents, Bernard's latest invention is a method for screening compounds capable of inhibiting the binding between the transcription factor STAT1 and the transcription factor USF1. This method includes a series of steps where candidate compounds are tested for their ability to inhibit the interaction between these crucial polypeptides. The process involves providing the necessary polypeptides, contacting them with candidate compounds, and measuring the binding activity to ascertain the effectiveness of the compounds.
Additionally, Bernard has developed methods for identifying inhibitors that suppress the activity of transacting proteins essential for the general control of vertebrate MHC class II gene expression. This invention holds potential implications for treating diseases associated with the aberrant expression of these genes through targeted pharmaceutical compositions.
Career Highlights
Throughout his professional journey, Bernard has worked with various companies, including Novimaune S.A., where he likely contributed his expertise in molecular biology and innovative research methods. His work in these organizations illustrates his commitment to advancing scientific knowledge and technological capabilities in the field.
Collaborations
In pursuit of innovation, Bernard has collaborated with notable coworkers such as Eric O Long and Claire T Wake. These partnerships underscore the collaborative nature of scientific research, where diverse expertise converges to promote breakthroughs in technology and medicine.
Conclusion
Bernard F Mach's inventive efforts reflect a blend of creativity and scientific rigor, resulting in advancements that may significantly impact medical research and therapeutic approaches. Through his patents, he continues to contribute to the evolution of molecular biology, paving the way for future innovations that could enhance our understanding of complex biological systems.